Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical combination enema for solitary rectal ulcer syndrome
IRCT20230425057990N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of prednisolone, sucralfate and metronidazole in solitary rectal ulcer syndrome (SRUS), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Bleeding, Mucus secretion and 2 more. Started Dec 2022; status: completed.
02
Drugs
prednisolonesucralfatemetronidazole
03
Conditions
solitary rectal ulcer syndrome (SRUS)
Beyond the preview
Go deeper on IRCT20230425057990N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230425057990N1.